Recent research has demonstrated the existence of stem cells in MDS that irregularly present specific antigens, such as IL1RAP, CD25, CD366, and CLL-1, that are potentially linked to high-risk diseases [35]. This evidence concerns the gene CLEC12A and myelodysplastic syndrome.